Work

Immunological and metabolic optimization of tumor neoantigen vaccines

Year: 2025

Type: article

Abstract: Tumor initiation and progression are highly intricate biological processes, and mutation-driven tumorigenesis is a primary underlying cause. Personalized cancer vaccines have been developed to exploit these specific mutations, particularly in the form of tumor neoantigens, to induce immune responses

Source: Cancer Biology and Medicine

DOI: 10.20892/j.issn.2095-3941.2025.0445

Authors: Xiafeng Wang, Zhangping Huang, Lin Peng, Shuoxi Xu, Jianfeng Huang, Ji Wang

Institutions: Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,500